Search research articles
Contact Us
Filters
Showing results (211-220 of 421) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2015
Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
Mitch Dowsett, Ivana Sestak, Richard Buus, et al.
Journal of the National Cancer Institute
|
April 13, 2011
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study
Jack Cuzick, Jane Warwick, Elizabeth Pinney, et al.
American Journal of Clinical Pathology
|
August 16, 2015
Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study
Jennifer L Reid, Thomas C Wright, Mark H Stoler, et al.
American Journal of Clinical Pathology
|
January 18, 2015
Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study
Phillip E Castle, Jack Cuzick, Mark H Stoler, et al.
Vaccine
|
October 14, 2008
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries
Jack Cuzick, Marc Arbyn, Rengaswamy Sankaranarayanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2011
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors
Gong Tang, Jack Cuzick, Joseph P Costantino, et al.
Journal of Neurology
|
May 5, 2019
Screening performance of abbreviated versions of the UPSIT smell test
Theresita Joseph, Stephen D Auger, Luisa Peress, et al.
Annals of Internal Medicine
|
November 15, 2016
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis
Marc Arbyn, Lan Xu, Freija Verdoodt, et al.
The Prostate
|
April 27, 2007
Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial
Stijn Roemeling, Monique J Roobol, Suzie J Otto, et al.
Biomarkers in Medicine
|
November 18, 2014
DNA methylation of PITX2 predicts poor survival in men with prostate cancer
Nataša Vasiljević, Amar S Ahmad, Paul D Carter, et al.
Page
of 43
Search research articles
Search
Showing results (211-220 of 421) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2015
Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
Mitch Dowsett, Ivana Sestak, Richard Buus, et al.
Journal of the National Cancer Institute
|
April 13, 2011
Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study
Jack Cuzick, Jane Warwick, Elizabeth Pinney, et al.
American Journal of Clinical Pathology
|
August 16, 2015
Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study
Jennifer L Reid, Thomas C Wright, Mark H Stoler, et al.
American Journal of Clinical Pathology
|
January 18, 2015
Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study
Phillip E Castle, Jack Cuzick, Mark H Stoler, et al.
Vaccine
|
October 14, 2008
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries
Jack Cuzick, Marc Arbyn, Rengaswamy Sankaranarayanan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2011
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factors
Gong Tang, Jack Cuzick, Joseph P Costantino, et al.
Journal of Neurology
|
May 5, 2019
Screening performance of abbreviated versions of the UPSIT smell test
Theresita Joseph, Stephen D Auger, Luisa Peress, et al.
Annals of Internal Medicine
|
November 15, 2016
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis
Marc Arbyn, Lan Xu, Freija Verdoodt, et al.
The Prostate
|
April 27, 2007
Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial
Stijn Roemeling, Monique J Roobol, Suzie J Otto, et al.
Biomarkers in Medicine
|
November 18, 2014
DNA methylation of PITX2 predicts poor survival in men with prostate cancer
Nataša Vasiljević, Amar S Ahmad, Paul D Carter, et al.
Page
of 43